C-RAD is pleased to announce that Catalyst+ HD™ has been successfully validated at the MVZ Prof. Dr. Uhlenbrock & Partner, Medical Centre in Dortmund, Germany for use with their new Elekta Harmony linear accelerators. Elekta and C-RAD continue to work together driving the development of Surface Guided Radiation Therapy (SGRT) as the standard of care in Radiotherapy.

The installation in Dortmund is yet another milestone in this endeavor and the site is now one of the only hospitals in the world with this combined state-of-the art technology, enabling the clinic to offer their patients the best care available today.

All Elekta linear accelerators (linacs) are now certified for compatibility with the full capabilities of the Catalyst family of products. Including patient positioning, real time motion monitoring and respiratory gated treatment, automated couch adjustments using the Elekta’s MOSAIQ® interface, and automatic beam control using the Response™ interface, presenting all global customers with the opportunity to offer the same highly modern set-up for their treatment rooms.
“At MVZ Prof. Dr. Uhlenbrock and Partner we pride ourselves in always being in the forefront of the latest techniques and offering our patients the best available treatment in the field. The set-up with Elekta’s Harmony and C-RAD’s Sentinel™ and Catalyst+ HD™ will allow us to increase our treatment efficiency as well as our patient safety, something that lies at the heart of our strong focus for state-of-the-art patient service.” says Prof. Dr. Detlev Uhlenbrock (Managing Director of MVZ Prof. Dr. Uhlenbrock und Partner).

Catalyst+ HD has been validated for interoperability with the Elekta Versa HD™, Infinity™ and Synergy ® linear accelerators, and we are pleased to announce that the Catalyst is the first SGRT system available and validated for use with the Elekta Harmony.

A cancer treatment system designed to meet healthcare centres’ need for a productive, precise, and versatile radiotherapy treatment system, Elekta Harmony perfectly balances productivity, versatility, and precision without compromise, making it a solution for both mature and developing markets.

“Harmony is designed to allow centres to increase patient throughput without compromising on precision or versatility to treat a wide patient population. Validating Catalyst+ HD with Harmony is a next step in ensuring we provide the clinical versatility our customers expect while recognising the growing demand for Surface Image Guidance in radiation therapy,” says Elekta’s Marie Macary, Vice President and Head of Marketing and Sales, Linac Solutions.

Rad Oncology Homepage